2025 SPS Seattle | Taletrectinib Pushing Boundaries in ROS1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Date of Release
October 5th, 2025
%20(dragged)-1759605261217.webp&w=3840&q=75)
-1759525827965.webp&w=3840&q=75)